Madrigal Pharmaceuticals
MDGL
MDGL
226 hedge funds and large institutions have $4.62B invested in Madrigal Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 91 increasing their positions, 58 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
57% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 58
10% more funds holding
Funds holding: 205 → 226 (+21)
6.9% more ownership
Funds ownership: 94.02% → 100.92% (+6.9%)
Holders
226
Holding in Top 10
14
Calls
$310M
Puts
$165M
Top Buyers
| 1 | +$140M | |
| 2 | +$117M | |
| 3 | +$98.3M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$77.3M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$75.1M |
Top Sellers
| 1 | -$83.8M | |
| 2 | -$61.6M | |
| 3 | -$37M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$32.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$25.3M |